Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1726-1733

  Sakai, Masakazu ^a   Biwa, Takeshi ^a   Matsumura, Takeshi ^a   Takemura, Toru ^a   Matsuda, Hirofumi ^a   Anami, Yoshichika ^a   Sasahara, Takayuki ^a   Kobori, Shozo ^b   Shichiri, Motoaki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Atherosclerosis; Dexamethasone; Glucocorticoids; Macrophage growth; Oxidized LDL

Indexed keywords

DEXAMETHASONE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CORTICOSTEROID THERAPY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0032996677     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1726     Document Type: Article

References (61)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
3. Palinski W, Rosenfeld ME., Ylä-Hertluala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
4. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
5. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation inhuman coronary arteries. Proc Natl Acad Sci U S A. 1990;87: 4600-4604.
6. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1990;10:680-687.
7. Spagnoli LG, Orlandi A, Santeusanio G. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis. 1991;88:87-92.
8. Yui S, Sasaki T, Miyzaki A, Horiuchi S, Yamazaki M. Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb. 1993;13:331-337.
9. Martens JS, Reiner NE, Herrena-Velit P, Steinbrecher UP. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein. J Biol Chem. 1998;273:4915-4920.
10. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M, Shichiri M, Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem. 1994;269:31430-31435.
11. Sato Y, Kobori S, Sakai M, Yano T, Higashi T, Matsumura T, Morikawa W, Terano T, Miyazaki A, Horiuchi S, Shitiri M. Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-β activation. Atherosclerosis. 1996;125:15-26.
12. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki Y, Shichiri M, Horiuchi S. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derivcd macrophages. Arterioscler Thromb Vasc Biol. 1996;16:600-605.
13. Sakai M, Miyazaki A, Hakamata H, Kodama T, Suzuki H, Kobori S, Shichiri M, Horiuchi S. The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J Biol Chem. 1996;271: 27346-27352.
14. Sakai M, Shichiri M, Hakamata H, Horiuchi S. Endocytosed lysophosphatidylcholine, through the scavenger receptor, play an essential role in oxidized low density lipoprotein-induced macrophage proliferation. Trends Cardiovasc Med. 1998;8:119-124.
15. Biwa T, Hakamata H, Sakai M, Miyazaki A, Suzuki H, Kodama T, Shichiri M, Horiuchi S. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J Biol Chem. 1998;273:28305-28313.
16. Makheja AN, Bloom S, Muesing R, Simon T, Bailey JM. Antiinflammatory drugs in experimental atherosclerosis in WHHL rabbits and inhibition by cortisone acetate. Atherosclerosis. 1989;76:155-161.
17. Naito M, Yasue M, Asai K, Yamada K, Hayashi T, Kuzuya M, Funaki C, Yoshinine N, Kuzuya F. Effects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. J Nutr Sci Vitamin. 1992;38: 255-264.
18. Hayashi H, Nomoto A, Mutoh S, Yamaguchi I, Ono T. Role of inflammatory response in initiation of atherosclerosis: effects of antiinflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery. Atherosclerosis. 1991;91:107-116.
19. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 1994;93:1243-1249.
20. Van Put DJ, Van Hove CE, De Meyer GR, Wuyts F, Herman AG, Bult H. Dexamethasone influences intimai thickening and vascular reactivity in the rabbit collared carotid artery. Eur J Pharmacol. 1995;294:753-761.
21. Voisard R, Seitzer U, Baur R, Dartsch PC, Osterhues H, Hoher M, Hombach V. Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. Int J Cardiol. 1994;43: 257-267.
22. Yamada K, Naito M, Hayashi T, Asai K, Yoshimine N, Iguchi A. Effects of dexamethasone on migration of human monocytes in response to oxidized beta-very low density lipoprotein. Artery. 1993;20:253-267.
23. Prescott MF, McBride CK, Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol. 1989;135: 835-846.
24. Asai K, Funaki C, Hayashi T, Yamada K, Naito M, Kuzuya M, Yoshida F, Yoshimine N, Kuzuya F. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits: possible mechanisms. Arterioscler Thromb Vasc Biol. 1993;13:892-899.
25. 2+-mediated oxidation. FEBS Lett. 1992;314: 199-202.
26. Miyazaki A, Rahim ATMA, Araki S, Morino Y, Horiuchi S. Chemical cross-linking alters high-density lipoprotein to be recognized by a scavenger receptor in rat peritoneal macrophages. Biochim Biophys Acta. 1991;1082:143-151.
27. Fogelman AM, Haberland ME, Seager J, Hokom M, Edwards. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res. 1981; 22:1131-1141.
28. Hakamata H, Miyazaki A, Sakai M, Sakamoto Y, Matsuda H, Kihara K, Horiuchi S. Differential effects of an acyl-coenzyme A: cholesterol acyltransferase inhibitor on HDL-induced cholesterol efflux from rat macrophage foam cells. FEBS Lett. 1995;363:29-32.
29. Miyazaki A, Sakai M, Suginohara Y, Hakamata H, Sakamoto Y, Horiuchi S. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem. 1994;269:5264-5269.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989.
31. Miyatake S, Otsuka T, Yokota T, Lee F, Arai K. Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J. 1985;4: 2561-2568.
32. Alonso S, Minty A, Bourlet Y. Comparison of three actin-coding sequences in the mouse: evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol. 1986;23:11-22.
33. Agarwai MK. The antiglucocorticoid action of mifepristone. Pharmacol Therapeut. 1996;70:183-213.
34. Hirsch LJ, Mazzone T. Dexamethasone modulates lipoprotein metabolism in cultured human monocyte-derived macrophages: stimulation of scavenger receptor. J Clin Invest. 1986;77:485-490.
35. Moulton KS, Wu H, Barnett J, Parthasarathy S, Glass CK. Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences. Proc Natl Acad Sci U S A. 1992; 89:8102-8106.
36. Hamilton JA. Glucocorticoids and prostaglandin inhibit the induction of macrophage DNA synthesis by macrophage growth factor and phorbol ester. J Cell Physiol. 1983;115:67-74.
37. Gewert K, Sundler R. Dexamethasone down-regulates the 85 kDa phospholipase A2 in mouse macrophages and suppresses its activation. Biochem J. 1995;307:499-504.
38. Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trend Genet. 1988;4:309-314.
39. Evans RM. The steroid and thyroid hormone receptor family. Science. 1988;240:889-895.
40. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072: 129-157.
41. Brorson KA, Beverly B, Rang S-M, Lenaldo M, Schwartz RH. Transcriptional regulation of cytokine genes in nontransformed T Cells. J Immunol. 1991;147:3601-3609.
42. Gasson JC. Molecular Physiology of Granulocyte-Macrophage Colony-Stimulating Factor. Blood. 1991;77:1131-1145.
43. Sugimoto K, Tuboi A, Miyatake S, Arai K, Arai N. Inducible and non-inducible factors co-operatively activate the GM-CSF promoter by interacting with two adjacent DNA motifs. Inter Immunol. 1990;2: 787-794.
44. Masuda ES, Tokumitu H, Tsuboi A, Shilomai J, Hung P, Arai K-I, Arai N. The granulocyte-macrophage colony-stimulating factor promoter cisacting element CLEO mediates induction signals in T cells and is recognized by factors related to AP-1 and NFAT. Mol Cell Biol. 1993;13: 7399-7407.
45. Wang C-Y, Bassuk AG, Boise LH, Thompson CB, Bravo R, Leiden JM. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol Cell Biol. 1994;14:1153-1159.
46. Tuboi A, Muramatsu M, Tsutsumi A, Arai K, Arai N. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-κB/AP-1 in T cells. Biochem Biophys Res Commun. 1994;199:1064-1072.
47. Matsumura T, Sakai M, Kobori S, Biwa T, Takemura T, Matsuda H, Hakamata H, Horiuchi S. Shichiri M. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low density lipoprotein-induced macrophage growth. Arterioscler Thromb Vasc Biol. 1997;17:3013-3020.
48. Ares MPS, Kallin B, Eriksson J, Nelson J. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:1584-1590.
49. Chen YH, Desai P, Shiao RT, Lavelle D, Haleem A, Chen J. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood. 1996;87:314-323.
50. Nakano T, Raines EW, Abraham JA, Wenzel FG 4th, Higashiyama S, Klagburn M, Ross R. Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor in human aortic smooth muscle cells. J Biol Chem. 1993;268:22941-22947.
51. Fagot D, Buquet-Fagot C, Mester J. Antimitogenic effects of dexamethasone in chemically transformed mouse fibroblasts. Endocrinology. 1991; 129:1033-1041.
52. Bigsby RM, Cunha GR. Progesterone and dexamethasone inhibition of uterine epithelial proliferation in two models of estiogen-independent growth. Am J Obstet Gynecol. 1988;158:646-650.
53. Sanchez I, Goya L, Vallerga AK, Firestone GL. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression. Cell Growth Differ. 1993;4:215-225.
54. Ramos RA, Nishiono Y, Maiyar AC, Simon KE, Ridder CC, Ge Y, Firestone GL. Glucocorticoid-stimulate CCAAT/enhancer binding protein alpha expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells. Molec Cell Biol. 1996; 16:5288-5301.
55. Cha HH, Cram EJ, Wang EC, Huang AJ, Kasler HG, Firestone GL. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21 waf1/cip1 promoter in rat hepatoma cells. J Biol Chem. 1998;273: 1998-2007.
56. Corroyer S, Nabeyrat E, Clement A. Involvement of the cell cycle inhibitor CIP1/WAFI in lung alveolar epithelial cell growth arrest induced by glucocorticoids. Endocrinology. 1997;138:3677-3685.
57. Ramalingam A, Hirai A, Thimpson EA. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21 Cip. Mol Endocrinol. 1997;11:577-586.
58. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med. 1986;80:925-929.
59. Maxwell SR, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J. 1994;70:863-870.
60. Kalbak K. Incidence of atherosclerosis in patients with rheumatoid arthritis received long-term corticosteroid therapy. Ann Rheum Dis. 1972; 31:196-201.
61. Bulkley BH, Roberts WC. The heart in systematic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med. 1975;58:246-264.